ALVR
AlloVir Inc

978
Loading...
Loading...
Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases. The company is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6

Frequently Asked Questions

What is Market Cap of AlloVir Inc?
What is the 52-week high for AlloVir Inc?
What is the 52-week low for AlloVir Inc?
What is AlloVir Inc stock price today?
What was AlloVir Inc stock price yesterday?
What is the PE ratio of AlloVir Inc?
What is the Price-to-Book ratio of AlloVir Inc?
What is the 50-day moving average of AlloVir Inc?
How many employess does AlloVir Inc has?

Latest ALVR News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.